治疗代谢综合征相关疾病的GABA激动剂和治疗或预防I型糖尿病的GABA组合

在某些实施方式中,提供了缓解代谢综合征相关的一种或多种症状或紊乱的治疗或预防方法。在各种实施方式中,所述方法包括给予有此需要的对象缓解所述一种或多种症状有效量的GABA受体激动剂。在某些实施方式中,提供了预防或治疗I型糖尿病和相关病理性状态的方法,所述方法包括联用GABA或GABA激动剂与某些其它化合物(例如,对I型糖尿病具有治疗作用的一种或多种抗原(例如,GAD)和/或抗-CD3抗体、抗-CD20抗体、醋酸艾塞那肽和/或胰岛素原治疗剂)。 In certain embodiments methods are provided for the therapeutic or prophylact...

Full description

Saved in:
Bibliographic Details
Format Patent
LanguageChinese
Published 12.08.2022
Subjects
Online AccessGet full text

Cover

More Information
Summary:在某些实施方式中,提供了缓解代谢综合征相关的一种或多种症状或紊乱的治疗或预防方法。在各种实施方式中,所述方法包括给予有此需要的对象缓解所述一种或多种症状有效量的GABA受体激动剂。在某些实施方式中,提供了预防或治疗I型糖尿病和相关病理性状态的方法,所述方法包括联用GABA或GABA激动剂与某些其它化合物(例如,对I型糖尿病具有治疗作用的一种或多种抗原(例如,GAD)和/或抗-CD3抗体、抗-CD20抗体、醋酸艾塞那肽和/或胰岛素原治疗剂)。 In certain embodiments methods are provided for the therapeutic or prophylactic amelioration of one or more symptoms or disorders associated with metabolic syndrome. In various embodiments the methods involve administering to a subject in need thereof, a GABA receptor agonist, in an amount sufficient to ameliorate said one or more symptoms. In certain embodiments methods are provided for the prophylaxis or treatment of type I diabetes and related pathologies that involve the use of GABA or GABA agonists in combination with certain other compounds (e.g., one more antigens (e.g., GAD) that have a therapeutic effect in type I diabetes and/or an anti-CD3 antibody, an anti-CD20 antibody, exendin-4, and/or or a pro-insulin therapeutic).
Bibliography:Application Number: CN201610831898